Clinical trials
Terminated Sudden Infant Death trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aldagen | 1 |
| Duke University | 1 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 1 |
| Sangamo Therapeutics | 1 |
| Shire | 1 |
| Talaris Therapeutics Inc. | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sudden Infant Death | 7 |
| Mucopolysaccharidosis II | 6 |
| Mucopolysaccharidosis I | 4 |
| Mucopolysaccharidosis VI | 3 |
| Adrenoleukodystrophy | 2 |
| Leukodystrophy, Globoid Cell | 2 |
| Leukodystrophy, Metachromatic | 2 |
| Mucopolysaccharidoses | 2 |
| Mucopolysaccharidosis III | 2 |
| Sandhoff Disease | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.